Skip to main content
Thursday 28 September 2023
twitter linkedin facebook rss
User account menu
  • Sign up
Home
Pharmaphorum menu first category
  • News
  • Views & Analysis
  • Deep Dive
  • Webinars
  • Podcasts
  • Videos
  • White Papers
  • Events
Pharmaphorum
close
    SECTION
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Videos
    • White Papers
    • Events
Channels
    Channels
    • Sales & Marketing
    • R&D
    • Digital
    • Market Access
    • Oncology
    • Patients
    • Spotlight
Channels
  • Sales & Marketing
  • R&D
  • Digital
  • Market Access
  • Oncology
  • Patients
  • Spotlight
    SUB NAVIGATION
    • Live Coverage
    • Partner Content
    • About us
    • Work for us
    • Contribute
    • Contact us
    • Advertise

Newsletters and Deep Dive digital magazine

 
 
Sign up
twitter linkedin facebook rss
Sign in

Editor's Picks

  1. ViiV’s injectable HIV PrEP drug Apretude gets EU okay
  2. Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals News
  3. Novo Nordisk Foundation pledges €127m for cell therapy plant
  4. Smartphone app cuts racial disparity in post-birth care
  5. Cancer Research UK earmarks £123m for Scottish R&D
News

CureVac claims advantage in BioNTech patent dispute

A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-ba

R&D
pharmaphorum podcast episode 98

Turning drug development on its head

Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho

Pharmaphorum Menu
  • Digital
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Market Access
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Oncology
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Patients
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • R&D
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Sales & Marketing
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Spotlight on
    • The Future of Generics
    • Frontiers Health 2023
    • World Without Disease Summit

Sign up for email newsletters and Deep Dive

 
 
rss facebook linkedin twitter
Pharmaphorum
About us Advertising Contact us
Contribute Cookie Policy Privacy Policy
Terms & Conditions Work for us
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company